Global Drug-Eluting Stent Market Research Report 2021

Global Drug-Eluting Stent Market Research Report 2021

Table of Contents
1 Drug-Eluting Stent Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Drug-Eluting Stent Segment by Type
1.2.1 Global Drug-Eluting Stent Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rapamycin Eluting Stent
1.2.3 Paclitaxel Eluting Stent
1.2.4 Everolimus Eluting Stent
1.2.5 Others
1.3 Drug-Eluting Stent Segment by Application
1.3.1 Drug-Eluting Stent Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stent Revenue 2016-2027
1.4.2 Global Drug-Eluting Stent Sales 2016-2027
1.4.3 Drug-Eluting Stent Market Size by Region: 2016 Versus 2021 Versus 2027
2 Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Drug-Eluting Stent Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug-Eluting Stent Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug-Eluting Stent Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug-Eluting Stent Manufacturing Sites, Area Served, Product Type
2.5 Drug-Eluting Stent Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stent Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stent Players Market Share by Revenue
2.5.3 Global Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stent Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug-Eluting Stent Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug-Eluting Stent Market Facts & Figures by Country
3.3.1 North America Drug-Eluting Stent Sales by Country
3.3.2 North America Drug-Eluting Stent Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 Europe Drug-Eluting Stent Sales by Country
3.4.2 Europe Drug-Eluting Stent Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug-Eluting Stent Market Facts & Figures by Region
3.5.1 Asia Pacific Drug-Eluting Stent Sales by Region
3.5.2 Asia Pacific Drug-Eluting Stent Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Latin America Drug-Eluting Stent Sales by Country
3.6.2 Latin America Drug-Eluting Stent Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug-Eluting Stent Sales by Country
3.7.2 Middle East and Africa Drug-Eluting Stent Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug-Eluting Stent Historic Market Analysis by Type
4.1 Global Drug-Eluting Stent Sales Market Share by Type (2016-2021)
4.2 Global Drug-Eluting Stent Revenue Market Share by Type (2016-2021)
4.3 Global Drug-Eluting Stent Price by Type (2016-2021)
5 Global Drug-Eluting Stent Historic Market Analysis by Application
5.1 Global Drug-Eluting Stent Sales Market Share by Application (2016-2021)
5.2 Global Drug-Eluting Stent Revenue Market Share by Application (2016-2021)
5.3 Global Drug-Eluting Stent Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boston Scientific Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Medtronic Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lepu Medical Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.5.4 B. Braun Melsungen Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Corporation Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.6.4 MicroPort Scientific Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cook Medical Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Terumo Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Biosensors International Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Corporation Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Balton Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Corporation Information
6.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.11.4 AlviMedica Medical Technologies Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Corporation Information
6.12.2 Biotronik Drug-Eluting Stent Description and Business Overview
6.12.3 Biotronik Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biotronik Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Corporation Information
6.13.2 Shandong JW Medical Drug-Eluting Stent Description and Business Overview
6.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Shandong JW Medical Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Corporation Information
6.14.2 Sino Medical Drug-Eluting Stent Description and Business Overview
6.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Sino Medical Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Corporation Information
6.15.2 Beijing AMSINO Drug-Eluting Stent Description and Business Overview
6.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Beijing AMSINO Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Drug-Eluting Stent Manufacturing Cost Analysis
7.1 Drug-Eluting Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug-Eluting Stent
7.4 Drug-Eluting Stent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug-Eluting Stent Distributors List
8.3 Drug-Eluting Stent Customers
9 Drug-Eluting Stent Market Dynamics
9.1 Drug-Eluting Stent Industry Trends
9.2 Drug-Eluting Stent Growth Drivers
9.3 Drug-Eluting Stent Market Challenges
9.4 Drug-Eluting Stent Market Restraints
10 Global Market Forecast
10.1 Drug-Eluting Stent Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug-Eluting Stent by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug-Eluting Stent by Type (2022-2027)
10.2 Drug-Eluting Stent Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug-Eluting Stent by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug-Eluting Stent by Application (2022-2027)
10.3 Drug-Eluting Stent Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug-Eluting Stent by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug-Eluting Stent by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drug-Eluting Stent Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drug-Eluting Stent Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug-Eluting Stent Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug-Eluting Stent Covered in This Study
Table 5. Global Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug-Eluting Stent Sales Share by Manufacturers (2016-2021)
Table 7. Global Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug-Eluting Stent Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug-Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug-Eluting Stent Manufacturing Sites and Area Served
Table 11. Manufacturers Drug-Eluting Stent Product Type
Table 12. Global Drug-Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug-Eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Stent as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug-Eluting Stent Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug-Eluting Stent Sales Market Share by Region (2016-2021)
Table 17. Global Drug-Eluting Stent Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug-Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug-Eluting Stent Sales Market Share by Country (2016-2021)
Table 20. North America Drug-Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug-Eluting Stent Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug-Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug-Eluting Stent Sales Market Share by Country (2016-2021)
Table 24. Europe Drug-Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug-Eluting Stent Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug-Eluting Stent Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug-Eluting Stent Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug-Eluting Stent Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug-Eluting Stent Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug-Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug-Eluting Stent Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug-Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug-Eluting Stent Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug-Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug-Eluting Stent Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug-Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug-Eluting Stent Revenue Market Share by Country (2016-2021)
Table 38. Global Drug-Eluting Stent Sales (K Units) by Type (2016-2021)
Table 39. Global Drug-Eluting Stent Sales Market Share by Type (2016-2021)
Table 40. Global Drug-Eluting Stent Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drug-Eluting Stent Revenue Share by Type (2016-2021)
Table 42. Global Drug-Eluting Stent Price (USD/Unit) by Type (2016-2021)
Table 43. Global Drug-Eluting Stent Sales (K Units) by Application (2016-2021)
Table 44. Global Drug-Eluting Stent Sales Market Share by Application (2016-2021)
Table 45. Global Drug-Eluting Stent Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug-Eluting Stent Revenue Share by Application (2016-2021)
Table 47. Global Drug-Eluting Stent Price (USD/Unit) by Application (2016-2021)
Table 48. Boston Scientific Corporation Information
Table 49. Boston Scientific Description and Business Overview
Table 50. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Boston Scientific Drug-Eluting Stent Product
Table 52. Boston Scientific Recent Developments/Updates
Table 53. Medtronic Corporation Information
Table 54. Medtronic Description and Business Overview
Table 55. Medtronic Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Medtronic Drug-Eluting Stent Product
Table 57. Medtronic Recent Developments/Updates
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Business Overview
Table 60. Abbott Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Drug-Eluting Stent Product
Table 62. Abbott Recent Developments/Updates
Table 63. Lepu Medical Corporation Information
Table 64. Lepu Medical Description and Business Overview
Table 65. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Lepu Medical Drug-Eluting Stent Product
Table 67. Lepu Medical Recent Developments/Updates
Table 68. B. Braun Melsungen Corporation Information
Table 69. B. Braun Melsungen Description and Business Overview
Table 70. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. B. Braun Melsungen Drug-Eluting Stent Product
Table 72. B. Braun Melsungen Recent Developments/Updates
Table 73. MicroPort Scientific Corporation Information
Table 74. MicroPort Scientific Description and Business Overview
Table 75. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. MicroPort Scientific Drug-Eluting Stent Product
Table 77. MicroPort Scientific Recent Developments/Updates
Table 78. Cook Medical Corporation Information
Table 79. Cook Medical Description and Business Overview
Table 80. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Cook Medical Drug-Eluting Stent Product
Table 82. Cook Medical Recent Developments/Updates
Table 83. Terumo Corporation Information
Table 84. Terumo Description and Business Overview
Table 85. Terumo Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Terumo Drug-Eluting Stent Product
Table 87. Terumo Recent Developments/Updates
Table 88. Biosensors International Corporation Information
Table 89. Biosensors International Description and Business Overview
Table 90. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Biosensors International Drug-Eluting Stent Product
Table 92. Biosensors International Recent Developments/Updates
Table 93. Balton Corporation Information
Table 94. Balton Description and Business Overview
Table 95. Balton Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Balton Drug-Eluting Stent Product
Table 97. Balton Recent Developments/Updates
Table 98. AlviMedica Medical Technologies Corporation Information
Table 99. AlviMedica Medical Technologies Description and Business Overview
Table 100. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. AlviMedica Medical Technologies Drug-Eluting Stent Product
Table 102. AlviMedica Medical Technologies Recent Developments/Updates
Table 103. Biotronik Corporation Information
Table 104. Biotronik Description and Business Overview
Table 105. Biotronik Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Biotronik Drug-Eluting Stent Product
Table 107. Biotronik Recent Developments/Updates
Table 108. Shandong JW Medical Corporation Information
Table 109. Shandong JW Medical Description and Business Overview
Table 110. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Shandong JW Medical Drug-Eluting Stent Product
Table 112. Shandong JW Medical Recent Developments/Updates
Table 113. Sino Medical Corporation Information
Table 114. Sino Medical Description and Business Overview
Table 115. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Sino Medical Drug-Eluting Stent Product
Table 117. Sino Medical Recent Developments/Updates
Table 118. Beijing AMSINO Corporation Information
Table 119. Beijing AMSINO Description and Business Overview
Table 120. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Beijing AMSINO Drug-Eluting Stent Product
Table 122. Beijing AMSINO Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Drug-Eluting Stent Distributors List
Table 126. Drug-Eluting Stent Customers List
Table 127. Drug-Eluting Stent Market Trends
Table 128. Drug-Eluting Stent Growth Drivers
Table 129. Drug-Eluting Stent Market Restraints
Table 130. Global Drug-Eluting Stent Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Drug-Eluting Stent Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Drug-Eluting Stent Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Drug-Eluting Stent Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Drug-Eluting Stent Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Drug-Eluting Stent Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Drug-Eluting Stent Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug-Eluting Stent
Figure 2. Global Drug-Eluting Stent Market Share by Type in 2020 & 2027
Figure 3. Rapamycin Eluting Stent Product Picture
Figure 4. Paclitaxel Eluting Stent Product Picture
Figure 5. Everolimus Eluting Stent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug-Eluting Stent Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Others
Figure 12. Global Drug-Eluting Stent Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drug-Eluting Stent Market Size 2016-2027 (US$ Million)
Figure 14. Global Drug-Eluting Stent Sales 2016-2027 (K Units)
Figure 15. Global Drug-Eluting Stent Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Drug-Eluting Stent Sales Share by Manufacturers in 2020
Figure 17. Global Drug-Eluting Stent Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Drug-Eluting Stent Players: Market Share by Revenue in 2020
Figure 19. Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Drug-Eluting Stent Sales Market Share by Region (2016-2021)
Figure 21. Global Drug-Eluting Stent Sales Market Share by Region in 2020
Figure 22. Global Drug-Eluting Stent Revenue Market Share by Region (2016-2021)
Figure 23. Global Drug-Eluting Stent Revenue Market Share by Region in 2020
Figure 24. U.S. Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Drug-Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Drug-Eluting Stent by Type (2016-2021)
Figure 49. Sales Market Share of Drug-Eluting Stent by Application (2016-2021)
Figure 50. Sales Market Share of Drug-Eluting Stent by Application in 2020
Figure 51. Revenue Share of Drug-Eluting Stent by Application (2016-2021)
Figure 52. Revenue Share of Drug-Eluting Stent by Application in 2020
Figure 53. Manufacturing Cost Structure of Drug-Eluting Stent
Figure 54. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 55. Drug-Eluting Stent Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs